Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morihito Okada

Showing results (201-210 of 527) with videos related to

Pageof 53
Sort By:
Clinical Breast Cancer|December 3, 2014
The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trialHideo Shigematsu, Takayuki Kadoya, Norio Masumoto, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 7, 2020
Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancerAtsushi Kamigaichi, Yasuhiro Tsutani, Takahiro Mimae, et al.
Anticancer Research|February 5, 2020
Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by SurgeryManato Ohsawa, Yoichi Hamai, Manabu Emi, et al.
Annals of Surgical Oncology|September 13, 2022
S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II TrialKazuya Takamochi, Masahiro Tsuboi, Morihito Okada, et al.
Anticancer Research|September 9, 2018
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic EsophagusTakaoki Furukawa, Yoichi Hamai, Jun Hihara, et al.
Clinical Breast Cancer|June 26, 2014
Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsyHideo Shigematsu, Takayuki Kadoya, Norio Masumoto, et al.
The Annals of Thoracic Surgery|March 21, 2024
Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant TumorsTakahiro Mimae, Yoshihiro Miyata, Norifumi Tsubokawa, et al.
Clinical Lung Cancer|March 1, 2024
Clinical Significance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non-Small-Cell Lung CancerNorifumi Tsubokawa, Takahiro Mimae, Takeshi Mimura, et al.
World Journal of Surgery|May 17, 2024
Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomyRyosuke Hirohata, Yoichi Hamai, Manabu Emi, et al.
Japanese Journal of Clinical Oncology|April 27, 2024
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinomaYu Izaki, Takahiro Mimae, Atsushi Kagimoto, et al.
Pageof 53

Showing results (201-210 of 527) with videos related to

Sort By:
Pageof 53
Clinical Breast Cancer|December 3, 2014
The efficacy and safety of preoperative chemotherapy with triweekly abraxane and cyclophosphamide followed by 5-Fluorouracil, epirubicin, and cyclophosphamide therapy for resectable breast cancer: a multicenter clinical trialHideo Shigematsu, Takayuki Kadoya, Norio Masumoto, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|September 7, 2020
Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancerAtsushi Kamigaichi, Yasuhiro Tsutani, Takahiro Mimae, et al.
Anticancer Research|February 5, 2020
Tumor Response in Esophageal Squamous Cell Carcinoma Treated With Neoadjuvant Chemotherapy Followed by SurgeryManato Ohsawa, Yoichi Hamai, Manabu Emi, et al.
Annals of Surgical Oncology|September 13, 2022
S-1 + Cisplatin with Concurrent Radiotherapy Followed by Surgery for Stage IIIA (N2) Lung Squamous Cell Carcinoma: Results of a Phase II TrialKazuya Takamochi, Masahiro Tsuboi, Morihito Okada, et al.
Anticancer Research|September 9, 2018
Impact of Interval Between Neoadjuvant Chemoradiation and Surgery Upon Morbidity and Survival of Patients with Squamous Cell Carcinoma of Thoracic EsophagusTakaoki Furukawa, Yoichi Hamai, Jun Hihara, et al.
Clinical Breast Cancer|June 26, 2014
Role of FDG-PET/CT in prediction of underestimation of invasive breast cancer in cases of ductal carcinoma in situ diagnosed at needle biopsyHideo Shigematsu, Takayuki Kadoya, Norio Masumoto, et al.
The Annals of Thoracic Surgery|March 21, 2024
Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant TumorsTakahiro Mimae, Yoshihiro Miyata, Norifumi Tsubokawa, et al.
Clinical Lung Cancer|March 1, 2024
Clinical Significance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non-Small-Cell Lung CancerNorifumi Tsubokawa, Takahiro Mimae, Takeshi Mimura, et al.
World Journal of Surgery|May 17, 2024
Risk factors for recurrence of esophageal squamous cell carcinoma after pathological complete response to neoadjuvant therapy followed by esophagectomyRyosuke Hirohata, Yoichi Hamai, Manabu Emi, et al.
Japanese Journal of Clinical Oncology|April 27, 2024
Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinomaYu Izaki, Takahiro Mimae, Atsushi Kagimoto, et al.
Pageof 53